Subscribe to RSS
DOI: 10.1055/s-0038-1649335
Nervous System Infections and the Global Traveler
Publication History
Publication Date:
23 May 2018 (online)

Abstract
Neurological complications of infectious diseases are associated with high rates of morbidity and mortality. It is imperative that neurologists be up-to-date on current developments including typical and atypical presentations of neurological infections in travelers, diagnostic and treatment recommendations, and emerging pathogen resistance patterns to avoid fatal outcomes and long-term sequelae. This article will address concepts of emerging and reemerging infectious diseases, and will provide updates on the neurological manifestations of select emerging and reemerging infections, including Ebola virus, bacterial meningitis, enterovirus 71, Zika virus, cerebral malaria, and Japanese encephalitis. Emerging and reemerging neurotropic infectious diseases, including Zika virus, have recently been major global health threats. Factors contributing to the emergence of infectious diseases include closer contact with zoonoses, population growth in cities, globalization, environmental changes, and the rise in antibiotic resistance. Serotype replacement of bacterial meningitis, the possibility of viral persistence in the central nervous system in Ebola virus, antibiotic resistance of malaria, and the evolution of neurovirulent strains of Zika virus display some of the developing challenges that accompany various neurotropic infectious diseases. Neurologists should be aware of the factors contributing to the emergence and reemergence of neurotropic infectious diseases. As emerging and reemerging neurotropic infectious continue to be a major global health security threat, clinicians should be aware of the risks to travelers and current guidelines on prevention and management.
Keywords
emerging neurological infections - neurotropic infections in travelers - central nervous system infections - encephalitis - meningitisAuthors' Contributions
Savina Reid, drafting the manuscript for intellectual content.
Haley Thompson, drafting the manuscript for intellectual content.
Kiran Thakur, drafting and revising the manuscript for intellectual content.
-
References
- 1 Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog 2013; 9 (07) e1003467
- 2 Sullivan KE, Bassiri H, Bousfiha AA. , et al. Emerging infections and pertinent infections related to travel for patients with primary immunodeficiencies. J Clin Immunol 2017; 37 (07) 650-692
- 3 Leibovitch EC, Jacobson S. Vaccinations for neuroinfectious disease: a global health priority. Neurotherapeutics 2016; 13 (03) 562-570
- 4 Morse SS, Mazet JA, Woolhouse M. , et al. Prediction and prevention of the next pandemic zoonosis. Lancet 2012; 380 (9857): 1956-1965
- 5 Racaniello VR. Emerging infectious diseases. J Clin Invest 2004; 113 (06) 796-798
- 6 Ellerbrok H, Jacobsen S, Patel P. , et al. External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa. PLoS Negl Trop Dis 2017; 11 (05) e0005570
- 7 Chow FC, Glaser CA. Emerging and reemerging neurologic infections. Neurohospitalist 2014; 4 (04) 173-184
- 8 Morse SS. Factors in the emergence of infectious diseases. In: Price-Smith AT. , ed. Plagues and Politics. Global Issues Series. London: Palgrave Macmillan; 2001: 8-26
- 9 Freedman DO, Chen LH, Kozarsky PE. Medical considerations before international travel. N Engl J Med 2016; 375 (03) 247-260
- 10 Centers for Disease Control and Prevention. Zoonotic Diseases. Available at https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html . Accessed November 1, 2017
- 11 Holmes EC. The evolutionary genetics of emerging viruses. Annu Rev Ecol Evol Syst 2009; 40 (01) 353-372
- 12 Cleaveland S, Haydon DT, Taylor L. Overviews of pathogen emergence: which pathogens emerge, when and why?. In: Childs JE, Mackenzie JS, Richt JA. , eds. Wildlife and Emerging Zoonotic Diseases: The Biology, Circumstances and Consequences of Cross-Species Transmission. Berlin: Springer; 2007: 85-111
- 13 Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016; 374 (16) 1552-1563
- 14 Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis 2011; 52 (07) 911-916
- 15 Engering A, Hogerwerf L, Slingenbergh J. Pathogen-host-environment interplay and disease emergence. Emerg Microbes Infect 2013; 2 (02) e5
- 16 Mandl JN, Ahmed R, Barreiro LB. , et al. Reservoir host immune responses to emerging zoonotic viruses. Cell 2015; 160 (1–2): 20-35
- 17 Van Boeckel TP, Gandra S, Ashok A. , et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14 (08) 742-750
- 18 Graham JP, Boland JJ, Silbergeld E. Growth promoting antibiotics in food animal production: an economic analysis. Public Health Rep 2007; 122 (01) 79-87
- 19 UNWTO. Strong tourism results in the first part of 2017. Press release no. 17088. July 14, 2017
- 20 UNWTO. UNWTO tourism highlights. 2016. Available at: https://www.e-unwto.org/doi/pdf/10.18111/9789284418145 . Accessed July 14, 2017
- 21 Tatem AJ, Rogers DJ, Hay SI. Global transport networks and infectious disease spread. Adv Parasitol 2006; 62: 293-343
- 22 Zhang Q, Sun K, Chinazzi M. , et al. Spread of Zika virus in the Americas. Proc Natl Acad Sci U S A 2017; 114 (22) E4334-E4343
- 23 Killeen GF, Fillinger U, Kiche I, Gouagna LC, Knols BG. Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?. Lancet Infect Dis 2002; 2 (10) 618-627
- 24 Liang L, Gong P. Climate change and human infectious diseases: a synthesis of research findings from global and spatio-temporal perspectives. Environ Int 2017; 103: 99-108
- 25 EPA. Sanitary sewer overflows [database on the Internet]. 1996. Available at: https://www3.epa.gov/npdes/pubs/ssodesc.pdf . Accessed October 12, 2017
- 26 Ostfeld RS. Biodiversity loss and the rise of zoonotic pathogens. Clin Microbiol Infect 2009; 15 (Suppl. 01) 40-43
- 27 Keesing F, Belden LK, Daszak P. , et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 2010; 468 (7324): 647-652
- 28 Morin CW, Comrie AC, Ernst K. Climate and dengue transmission: evidence and implications. Environ Health Perspect 2013; 121 (11–12): 1264-1272
- 29 Paz S, Semenza JC. El Niño and climate change--contributing factors in the dispersal of Zika virus in the Americas?. Lancet 2016; 387 (10020): 745
- 30 Centers for Disease Control and Prevention. Advising travelers with specific needs. Immunocompromised travelers [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/advising-travelers-with-specific-needs/immunocompromised-travelers . Accessed June 11, 2017
- 31 Billioux BJ. Neurological complications and sequelae of Ebola virus disease. Curr Infect Dis Rep 2017; 19 (05) 19
- 32 Billioux BJ, Smith B, Nath A. Neurological complications of Ebola virus infection. Neurotherapeutics 2016; 13 (03) 461-470
- 33 Centers for Disease Control and Prevention. Ebola virus disease distribution map: cases of Ebola virus disease in Africa, 1976–2016 [database on the Internet]. 2016. Available at: https://www.cdc.gov/vhf/ebola/outbreaks/history/distribution-map.html . Accessed July 20, 2017
- 34 Centers for Disease Control and Prevention. Infectious diseases related to travel: tuberculosis [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/tuberculosis . Accessed May 31, 2017
- 35 Centers for Disease Control and Prevention. Ebola fact sheet [database on the Internet]. 2015. Available at: https://www.cdc.gov/vhf/ebola/pdf/ebola-factsheet.pdf . Accessed August 28, 2017
- 36 Fischer II WA, Wohl DA. Confronting Ebola as a sexually transmitted infection. Clin Infect Dis 2016; 62 (10) 1272-1276
- 37 Caswell RJ, Manavi K. Emerging sexually transmitted viral infections: 1. Review of Ebola virus disease. Int J STD AIDS 2017; 28 (13) 1352-1359
- 38 Clark DV, Kibuuka H, Millard M. , et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 2015; 15 (08) 905-912
- 39 Bowen L, Smith B, Steinbach S. , et al. Survivors of Ebola virus disease have persistent neurological deficits (S53. 003). Neurology 2016; 86 (16 Supplement): S53
- 40 Jacobs M, Rodger A, Bell DJ. , et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 2016; 388 (10043): 498-503
- 41 Billioux BJ, Nath A, Stavale EJ. , et al; Partnership for Research on Ebola Virus in Liberia (PREVAIL) III Study Group. Cerebrospinal fluid examination in survivors of Ebola virus disease. JAMA Neurol 2017; 74 (09) 1141-1143
- 42 World Health Organization. A Preliminary Report, 21 May 2015: Health worker Ebola infections in Guinea, Liberia and Sierra Leone [database on the Internet]. 2015. Available at: http://apps.who.int/iris/bitstream/10665/171823/1/WHO_EVD_SDS_REPORT_2015.1_eng.pdf?ua=1&ua=1 . Accessed August 15, 2017
- 43 Centers for Disease Control and Prevention. Ebola diagnosis [database on the Internet]. 2015. Available at: https://www.cdc.gov/vhf/ebola/diagnosis/index.html . Accessed August 12, 2017
- 44 Heckenberg SG, Brouwer MC, van de Beek D. Bacterial meningitis. Handb Clin Neurol 2014; 121: 1361-1375
- 45 Chandran A, Herbert H, Misurski D, Santosham M. Long-term sequelae of childhood bacterial meningitis: an underappreciated problem. Pediatr Infect Dis J 2011; 30 (01) 3-6
- 46 World Health Organization. Meningococcal meningitis [database on the Internet]. 2015. Available at: http://www.who.int/mediacentre/factsheets/fs141/en/ . Accessed August 28, 2017
- 47 World Health Organization. Tuberculosis: fact sheet [database on the Internet]. 2017. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/ . Accessed May 20, 2017
- 48 World Health Organization. Epidemic meningitis control in countries of the African meningitis belt, 2016 [database on the Internet]. 2017. Available at: http://apps.who.int/iris/bitstream/10665/254901/1/WER9213.pdf?ua=1 . Accessed August 22, 2017
- 49 Mohammed I, Iliyasu G, Habib AG. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa. Pathog Glob Health 2017; 111 (01) 1-6
- 50 Agier L, Martiny N, Thiongane O. , et al. Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overview. Int J Infect Dis 2017; 54: 103-112
- 51 Adriani KS, Brouwer MC, van de Beek D. Risk factors for community-acquired bacterial meningitis in adults. Neth J Med 2015; 73 (02) 53-60
- 52 UNWTO. Tourism highlights: 2017 Edition. Madrid: The World Tourism Organization; 2017
- 53 van de Beek D, Cabellos C, Dzupova O. , et al; ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; 22 (Suppl. 03) S37-S62
- 54 McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet 2016; 388 (10063): 3036-3047
- 55 Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol 2015; 42 (01) 29-45 , vii–viii
- 56 Chang P-C, Chen S-C, Chen K-T. The current status of the disease caused by Enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health 2016; 13 (09) 890
- 57 Wilson MR. Emerging viral infections. Curr Opin Neurol 2013; 26 (03) 301-306
- 58 Ong KC, Wong KT. Understanding enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathol 2015; 25 (05) 614-624
- 59 de Crom SC, Rossen JW, van Furth AM, Obihara CC. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr 2016; 175 (08) 1023-1029
- 60 World Health Organization. Hand, foot and mouth disease fact sheet [database on the Internet]. 2012. Available at: http://www.wpro.who.int/mediacentre/factsheets/fs_10072012_HFMD/en/ . Accessed September 1, 2017
- 61 Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr 2016; 59 (10) 395-401
- 62 Modlin JF, Kinney JS. Perinatal enterovirus infections. Adv Pediatr Infect Dis 1987; 2: 57-78
- 63 Yi E-J, Shin Y-J, Kim J-H, Kim T-G, Chang S-Y. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res 2017; 6 (01) 4-14
- 64 Lee T-C, Guo H-R, Su H-JJ, Yang Y-C, Chang H-L, Chen K-T. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J 2009; 28 (10) 904-910
- 65 Centers for Disease Control and Prevention. Non-polio enterovirus outbreaks and surveillance [database on the Internet]. 2016. Available at: https://www.cdc.gov/non-polio-enterovirus/outbreaks-surveillance.html . Accessed August 20, 2017
- 66 Cardosa MJ, Perera D, Brown BA. , et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 2003; 9 (04) 461-468
- 67 Casas-Alba D, de Sevilla MF, Valero-Rello A. , et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children's reference centre in Catalonia. Clin Microbiol Infect 2017; 23 (11) 874-881
- 68 Teoh H-L, Mohammad SS, Britton PN. , et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol 2016; 73 (03) 300-307
- 69 Zhang Q, MacDonald NE, Smith JC. , et al. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J 2014; 33 (05) 482-487
- 70 World Health Organization. A guide to clinical management and public health response for hand, foot and mouth disease (HFMD) [database on the Internet]. 2011. Available at: http://www.wpro.who.int/emerging_diseases/documents/HFMDGuidance/en/ . Accessed October 3, 2017
- 71 World Health Organization. Zika virus [database on the Internet]. 2017. Available at: http://www.who.int/mediacentre/factsheets/zika/en/ . Accessed May 13, 2017
- 72 Wei M, Meng F, Wang S. , et al. 2-year efficacy, immunogenicity, and safety of Vigoo Enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study. J Infect Dis 2017; 215 (01) 56-63
- 73 Reed Z, Cardosa MJ. Status of research and development of vaccines for enterovirus 71. Vaccine 2016; 34 (26) 2967-2970
- 74 Chen LH, Hamer DH. Zika virus: rapid spread in the western hemisphere. Ann Intern Med 2016; 164 (09) 613-615
- 75 Morris G, Barichello T, Stubbs B, Köhler CA, Carvalho AF, Maes M. Zika virus as an emerging neuropathogen: mechanisms of neurovirulence and neuro-immune interactions. Mol Neurobiol 2018; 55 (05) 4160-4184
- 76 Broutet N, Krauer F, Riesen M. , et al. Zika virus as a cause of neurologic disorders. N Engl J Med 2016; 374 (16) 1506-1509
- 77 Pan American Health Organization. Regional Zika epidemiological update (Americas) August 25, 2017 [database on the Internet]. 2017. Available at: http://www.paho.org/hq/index.php?option=com_content&view=article&id=11599%3Aregional-zika-epidemiological-update-americas&catid=8424%3Acontents&Itemid=41691&lang=en . Accessed August 27, 2017
- 78 Centers for Disease Control and Prevention. Zika travel information [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel/page/zika-travel-information . Accessed August 15, 2017
- 79 Reynolds MR, Jones AM, Petersen EE. , et al; U.S. Zika Pregnancy Registry Collaboration. Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure - U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep 2017; 66 (13) 366-373
- 80 Dasgupta S, Reagan-Steiner S, Goodenough D. , et al; Zika Virus Response Epidemiology and Laboratory Team. Patterns in Zika virus testing and infection, by report of symptoms and pregnancy status - United States, January 3-March 5, 2016. MMWR Morb Mortal Wkly Rep 2016; 65 (15) 395-399
- 81 Centers for Disease Control and Prevention. Diagnostic tests for Zika virus [database on the Internet]. 2017. Available at: https://www.cdc.gov/zika/hc-providers/types-of-tests.html . Accessed May 20, 2017
- 82 Cao-Lormeau VM, Blake A, Mons S. , et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387 (10027): 1531-1539
- 83 Brasil P, Pereira Jr JP, Moreira ME. , et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016; 375 (24) 2321-2334
- 84 Centers for Disease Control and Prevention. About 1 in 10 U.S. pregnant women with confirmed Zika infection had a fetus or baby with birth defects in 2016 [database on the Internet]. 2017. Available at: https://www.cdc.gov/media/releases/2017/p0404-zika-pregnancy.html . Accessed June 22, 2017
- 85 Mlakar J, Korva M, Tul N. , et al. Zika virus associated with microcephaly. N Engl J Med 2016; 374 (10) 951-958
- 86 Honein MA, Dawson AL, Petersen EE. , et al; US Zika Pregnancy Registry Collaboration. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017; 317 (01) 59-68
- 87 Vouga M, Baud D. Imaging of congenital Zika virus infection: the route to identification of prognostic factors. Prenat Diagn 2016; 36 (09) 799-811
- 88 Centers for Disease Control and Prevention. Zika virus: clinical evaluation and disease [database on the Internet]. 2017. Available at: https://www.cdc.gov/zika/hc-providers/preparing-for-zika/clinicalevaluationdisease.html . Accessed May 22, 2017
- 89 Centers for Disease Control and Prevention. Updated guidance for US laboratories testing for Zika virus infection July 24, 2017 [database on the Internet]. 2017. Available at: https://www.cdc.gov/zika/pdfs/laboratory-guidance-zika.pdf . Accessed July 7, 2017
- 90 Mailand MT, Frederiksen JL. Vaccines and multiple sclerosis: a systematic review. J Neurol 2017; 264 (06) 1035-1050
- 91 Centers for Disease Control and Prevention. Pregnant women [database on the Internet]. 2017. Available at: https://www.cdc.gov/zika/pregnancy/protect-yourself.html . Accessed August 8, 2017
- 92 Erra EO, Kantele A. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis. Expert Rev Vaccines 2015; 14 (09) 1167-1179
- 93 Centers for Disease Control and Prevention. Infectious diseases related to travel: Japanese encephalitis [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/japanese-encephalitis . Accessed May 13, 2017
- 94 World Health Organization. International travel and health: Japanese encephalitis [database on the Internet]. 2017. Available at: http://www.who.int/ith/diseases/japanese_encephalitis/en/ . Accessed June 23, 2017
- 95 Johnson BW, Goodman CH, Jee Y, Featherstone DA. Differential diagnosis of Japanese encephalitis virus infections with the Inbios JE Detect™ and DEN Detect™ MAC-ELISA kits. Am J Trop Med Hyg 2016; 94 (04) 820-828
- 96 Sarkari NB, Thacker AK, Barthwal SP. , et al. Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol 2012; 259 (01) 47-57
- 97 Chung CC, Lee SS, Chen YS. , et al. Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature. Infection 2007; 35 (01) 30-32
- 98 Solomon T, Dung NM, Kneen R. , et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002; 125 (Pt 5): 1084-1093
- 99 Campbell GL, Hills SL, Fischer M. , et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011; 89 (10) 766-774 , 774A–774E
- 100 Dung NM, Turtle L, Chong WK. , et al. An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis. J Neurol 2009; 256 (12) 2052-2060
- 101 Solomon T, Dung NM, Wills B. , et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003; 361 (9360): 821-826
- 102 Hoke Jr CH, Vaughn DW, Nisalak A. , et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992; 165 (04) 631-637
- 103 Centers for Disease Control and Prevention. Japanese encephalitis vaccine [database on the Internet]. 2015. Available at: https://www.cdc.gov/japaneseencephalitis/vaccine/index.html . Accessed May 27, 2017
- 104 Severe malaria. Trop Med Int Health 2014; (Suppl. 01) 7-131
- 105 Centers for Disease Control and Prevention. Infectious diseases related to travel: malaria [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/malaria . Accessed May 14, 2017
- 106 Bhatt S, Weiss DJ, Cameron E. , et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015; 526 (7572): 207-211
- 107 Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434 (7030): 214-217
- 108 Mung'Ala-Odera V, Snow RW, Newton CR. The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg 2004; 71 (2, Suppl): 64-70
- 109 Bejon P, Warimwe G, Mackintosh CL. , et al. Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 2009; 77 (05) 1917-1923
- 110 Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria--implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349 (16) 1510-1516
- 111 Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4 (12) 827-840
- 112 Dondorp AM, Lee SJ, Faiz MA. , et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008; 47 (02) 151-157
- 113 Seydel KB, Kampondeni SD, Valim C. , et al. Brain swelling and death in children with cerebral malaria. N Engl J Med 2015; 372 (12) 1126-1137
- 114 Idro R, Marsh K, John CC, Newton CRJ. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 2010; 68 (04) 267-274
- 115 Birbeck GL, Molyneux ME, Kaplan PW. , et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010; 9 (12) 1173-1181
- 116 Sahu PK, Satpathi S, Behera PK, Mishra SK, Mohanty S, Wassmer SC. Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches. Front Cell Infect Microbiol 2015; 5: 75
- 117 Jakka SR, Veena S, Atmakuri RM, Eisenhut M. Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis. Cerebrospinal Fluid Res 2006; 3: 8
- 118 Beare NAV, Lewallen S, Taylor TE, Molyneux ME. Redefining cerebral malaria by including malaria retinopathy. Future Microbiol 2011; 6 (03) 349-355
- 119 Maude RJ, Beare NA, Abu Sayeed A. , et al. The spectrum of retinopathy in adults with Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2009; 103 (07) 665-671
- 120 Burton M, Nyong'o O, Burton K. , et al. Retinopathy in Gambian children admitted to hospital with malaria. Trop Doct 2004; 34 (04) 214-218
- 121 Kampondeni SD, Potchen MJ, Beare NAV. , et al. MRI findings in a cohort of brain injured survivors of pediatric cerebral malaria. Am J Trop Med Hyg 2013; 88 (03) 542-546
- 122 Dondorp AM, Fanello CI, Hendriksen ICE. , et al; AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376 (9753): 1647-1657
- 123 Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev 2012; (06) CD005967
- 124 Ashley EA, Dhorda M, Fairhurst RM. , et al; Tracking Resistance to Artemisinin Collaboration (TRAC). Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014; 371 (05) 411-423
- 125 Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. ; Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008; 359 (24) 2619-2620
- 126 Daily JP. Malaria 2017: Update on the clinical literature and management. Curr Infect Dis Rep 2017; 19 (08) 28
- 127 World Health Organization. Malaria: responding to antimalarial drug resistance [database on the Internet]. 2017. Available at: http://www.who.int/malaria/areas/drug_resistance/overview/en/ . Accessed July 21, 2017
- 128 World Health Organization. Guidelines for the Treatment of Malaria. 3rd ed. Geneva: World Health Organization; 2015
- 129 Namutangula B, Ndeezi G, Byarugaba JS, Tumwine JK. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar J 2007; 6: 138
- 130 Centers for Disease Control and Prevention. Vaccines. Medicines. Advice [database on the Internet]. 2017. Available at: https://wwwnc.cdc.gov/travel . Accessed October 3, 2017
- 131 World Health Organization. Disease outbreak news (DONs) [database on the Internet]. 2017. Available at: http://www.who.int/csr/don/en/ . Accessed October 3, 2017
- 132 ProMED. Most recent alert [database on the Internet]. 2017. Available at: https://www.promedmail.org/ . Accessed October 3, 2017